Go to Contents Go to Navigation

Samsung BioLogics to set up lab in U.S.

General 16:29 January 16, 2020
Samsung BioLogics to set up lab in U.S.
Samsung BioLogics to set up lab in U.S.

Kim Tae-han (L), head of Samsung BioLogics, a biopharmaceutical affiliate of Samsung Group, announces a plan to establish a laboratory in San Francisco within the year during an investor relations session at the J.P. Morgan Healthcare Conference 2020 in the U.S. city on Jan. 15, 2020 (local time). The contract drug manufacturer provided this photo. (PHOTO NOT FOR SALE) (Yonhap)
(END)

16:29 January 16, 2020
HOME TOP
Send Feedback
How can we improve?
Thanks for your feedback!